News

Hepion Pharmaceuticals Implements Significant Reverse Stock Split

Hepion Pharmaceuticals Implements Significant Reverse Stock Split

Hepion Pharmaceuticals Reverse Stock Split Overview

Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a leading biopharmaceutical company, has announced an important corporate action that will significantly alter its stock structure. To better align with market requirements and enhance share value, the company will execute a 1-for-50 reverse stock split of its common shares. This move reflects a strategic initiative to elevate the bid price of its stock while maintaining compliance with the Nasdaq Capital Market's minimum bid price requirement.

Details of the Reverse Stock Split

The reverse stock split will be effective at 4:01 p.m. Eastern Time. Consequently, starting from March 18, 2025, the company's shares will begin trading on a split-adjusted basis. Each 50 shares presently being held will be consolidated into a single new share. Importantly, this adjustment will not impact any stockholder's overall percentage ownership, with the only exception being minor changes resulting from the treatment of fractional shares.

Impact on Shareholders

In practical terms, the reverse split will reduce the total number of outstanding shares from around 54.25 million to approximately 1.08 million. Any stockholder entitled to a fractional share following the split will see their interests rounded up to the nearest whole share, ensuring no shareholder is disadvantaged by this process. This approach aims to create more substantial overall share values, potentially benefiting all stockholders.

Reason Behind the Action

The company initiated this reverse stock split as part of its broader strategy to boost its share price and maintain its presence in the competitive Nasdaq Capital Market. This decision follows the annual meeting of stockholders, where participants expressed their support for this critical adjustment, showcasing a collective commitment to improve the company's market position.

Hepion's Development Pipeline

Hepion is known for its advanced work in the biopharmaceutical sector, particularly with Rencofilstat, a promising treatment for chronic liver conditions such as non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). Rencofilstat's potential to inhibit cyclophilins has made it a focal point in Hepion's clinical endeavors, garnering attention from various regulatory bodies.

Regulatory Recognition

The U.S. Food and Drug Administration has granted significant designations to Rencofilstat, including Fast Track and Orphan Drug status. These acknowledgments not only highlight the treatment's potential but also affirm Hepion's commitment to meeting critical health challenges in liver disease treatment.

Clinical Trials and Results

Recently, the company announced its approach to winding down the ASCEND-NASH clinical trial, a key Phase 2b study aimed at assessing the safety and efficacy of Rencofilstat over a year-long period. With 151 subjects enrolled and data being collated from ongoing safety assessments, Hepion is positioned well to leverage recent findings in future developments and structures.

Looking Ahead

The reverse stock split signifies a proactive measure by Hepion Pharmaceuticals to enhance its stock value and ensure continued compliance with market regulations. As the company moves forward, shareholders can anticipate updates regarding clinical developments and stock performance as they navigate this crucial phase.

Frequently Asked Questions

What is the purpose of the reverse stock split?

The reverse stock split aims to increase the stock bid price to meet Nasdaq's minimum bid price requirement.

How will the reverse stock split affect current shareholders?

Shareholders will see their number of shares reduced, but their percentage ownership will remain largely unchanged, except for minor adjustments due to fractional shares.

When does the reverse stock split take effect?

The effective date for the reverse stock split is March 18, 2025, starting at 4:01 PM Eastern Time.

What is Rencofilstat, and why is it important?

Rencofilstat is Hepion's lead drug candidate for treating liver diseases, recognized for its potential to significantly impact patient outcomes.

Where can I find more information about Hepion Pharmaceuticals?

Detailed information is available through the company’s official communications and filings on the SEC's website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 90

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 34

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 67

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 112

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 84

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 118

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 32

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading
GEYOTO’s RE+ Debut Shows Demand, Not Yet Scale Proof

Updated Category News Views 39

Desert-colored booths do not pay invoices, but a nearly sold-out stash of spare units is a lot more useful than the usual trade-show applause. GEYOTO’s first RE+ appearance, held November 17–19 at the Las Vegas Convention Center, produced the kind of early evidence a young energy-products brand needs: people stopped, handled the equipment, asked questions, made...

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 268

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Physician Compensation Management at Southwell

Updated Category News Views 112

Revolutionizing Physician Compensation with Clinician Nexus In a significant move towards streamlining physician compensation processes, Southwell, a notable health system in South Central Georgia, has partnered with Clinician Nexus, a leader in clinical workforce technology. This collaboration will introduce Clinician Nexus’ advanced physician compensation management...

Continue Reading
Transforming a $1000 Investment in Digital Realty Trust Today

Updated Category News Views 208

Long-Term Investing Success with Digital Realty Trust Digital Realty Trust (NYSE: DLR) has shown remarkable performance in the financial markets, surpassing typical market returns consistently over the last two decades. With an impressive annualized return of 11.8%, this company has proven its capability to deliver value to its investors. The Growth of Your Initial...

Continue Reading
Investigation Launched on Markforged Shareholder Deal Fairness

Updated Category News Views 89

So here’s the scoop: Ademi LLP has kicked off an investigation into Markforged Holding Corporation (NYSE: MKFG), and it’s not just for show. The focus? To unpack whether the company’s board is doing their job right in a deal that smells a bit fishy with Nano Dimension. A Stinky Deal Under this agreement, shareholders are looking at a measly $5.00 per share—sounds...

Continue Reading
Introducing Noel Ortega: A Transformative Leader at SAFCO

Updated Category News Views 179

SAFCO Welcomes New Leadership in Account Services Southern Auto Finance Company, LLC (SAFCO) is thrilled to announce that Noel Ortega has been appointed as the new Senior Vice President of Account Services. Mr. Ortega comes with a wealth of knowledge from over 20 years in the auto finance sector, emphasizing collections and outstanding customer service. Mr. Ortega's...

Continue Reading
BBG Expands Services with New Data Center Specialty Practice

Updated Category News Views 167

BBG Unveils New Data Center Specialty Practice BBG, a prominent figure in the national commercial real estate services arena, has recently launched a dedicated Data Center Specialty Practice to address the surging demand for valuation and advisory services within the mission-critical infrastructure domain. Leading the charge is Christopher M. Fudacz, a seasoned expert in...

Continue Reading